Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Phase 2 HORIZON Study of Melflufen in Relapsed/Refractory Multiple Myeloma Refractory to Daratumumab and/or Pomalidomide: Updated Efficacy and Safety

202 views
November 18, 2019
Comments 0
Login to view comments. Click here to Login